News & Discoveries

August 28, 2019

UCSF scientists who identified the only human gene known to promote “natural short sleep” have discovered a second.

August 22, 2019

Researchers discovered a scorpion toxin that targets the “wasabi receptor,” which they think it can be used as a tool for studying chronic pain and inflammation, and may eventually lead to the development of new kinds of non-opioid pain relievers.

August 15, 2019

In a paper researchers describe a technique that uses a special version of CRISPR developed at UCSF to systematically alter the activity of genes in human neurons generated from stem cells, the first successful merger of stem cell-derived cell types and CRISPR screening technologies.

August 12, 2019

Study Suggests Tau Tangles, Not Amyloid Plaques, Drive Daytime Napping That Precedes DementiaUCSF scientists show that Alzheimer’s disease directly attacks brain regions responsible for wakefulness during the day.

July 30, 2019

Study Is Step Toward One Day Treating People with Speech LossUCSF scientists have for the first time decoded spoken words and phrases in real time from the brain signals that control speech.

July 30, 2019

Since 2017, UCSF researchers Winston Chiong and Eddie Chang have led a collaborative neuroethics research project funded by the NIH.

July 29, 2019

Places Among Nation’s Most Renowned for Excellence in 15 Adult SpecialtiesFor the 21st year, UCSF Health has been listed among the top 10 hospitals nationwide in the prestigious U.S. News & World Report’s Best Hospitals survey.

July 11, 2019

With New Commitment, Couple’s Total Giving to ‘UCSF: The Campaign’ Reaches $50MThe Susan and Bill Oberndorf Foundation has made a new commitment of $25 million to UCSF psychiatry and the neurosciences, bringing its total giving to "UCSF: The Campaign" to $50 million.

July 05, 2019

Technology that Uncovered Antibody Has Potential to Identify Other Autoimmune DiseasesUsing advanced technology, scientists have discovered an autoimmune disease that appears to affect men with testicular cancer.

July 01, 2019

The commitment reflects the ambitions of Atlantic Philanthropies and its founder, Charles “Chuck” Feeney, to advance fairer, healthier and more inclusive societies.

Pages